Pfizer (PFE) DMA 200 (1968 - 2026)

Pfizer (PFE) DMA 200 (1968 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	DMA 200
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	49.54
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	947.65
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	213.13
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	219.96
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	103.94
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	329.36
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	128.92
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	25.85
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	53.21
10	Novartis Ag	109.78 Bn	109.09 Bn	-	141.18

Download Data